Biopharmaceutical companies are exploring new types of strategic partnerships to help them save time and money during the most challenging and costly stage of product
development–early-stage Phase I/II, pivotal Phase IIb/III and post-marketing clinical trials.

By working with the right strategic partner for these vital studies, biopharmaceutical companies can greatly increase efficiency in focusing their internal resources on the highest priorities – such as discovery research – while relying on their partners for a broad array of specialized knowledge and infrastructure.

Worldwide Biopharma has positioned itself to be a strategic partner despite study and emerging market complexities.

• Our principals re-engineered the logistics process for clinical trials in the Latin American Region by creating a specialized division to support this unique service niche.
• This was a key driver in the operations and business execution of two of the largest logistics networks operating today in the Americas and abroad.
• Our specialized teams will support your country-specific needs, while maintaining regulatory compliance to timely execute your clinical trial studies.
• Temperature-controlled packaging is available to guarantee stability of your clinical samples.
• Whatever the size of your study, we can plan and manage your pivotal trials from the beginning and throughout its duration.
• Worldwide Biopharma will work closely with your selected clinicians, study management and support teams, laboratory testing or long-term storage vendor to ensure all deadlines are met – reducing costs, minimizing risks and delays, and increasing compliance.